目的:探讨倍他乐克在心肌病慢性心衰中的治疗作用。方法:选择冠心病缺血性心肌病、扩张性心肌病慢性心衰病人39例,在使用常规利尿、ACEI、强心剂等基础上,加用倍他乐克,缓慢递增剂量,比较用药前、后12周心脏指标变化,评估临床有效性。结果:纳入统计范围38例。治疗后12周后显效11例,有效22例,总有效率为86.84%,无效5例,占13.16%。结论:在常规抗心衰治疗基础上加用倍他乐克效果显著。 Objective: To explore the therapeutic effect of Betaloc in cardiomyopathy chronic heart failure. Methods: Thirty-nine patients with coronary heart disease with ischemic cardiomyopathy and dilated cardiomyopathy were enrolled in this study. On the basis of conventional diuresis, ACEI and tonicity, Betaloc was added slowly and slowly, Twelve-week changes in cardiac indicators to assess clinical efficacy. Results: Included in the statistical range of 38 cases. After 12 weeks of treatment, 11 cases were markedly effective and 22 cases were effective. The total effective rate was 86.84%, and 5 cases were ineffective, accounting for 13.16%. Conclusion: Betaloc can be effective in the treatment of conventional anti-heart failure.